Organic anion transporting polypeptide 2B1 (OATP2B1), an expanded substrate profile, does it align with OATP2B1’s hypothesized function?

References

• Bauer M, Matsuda A, Wulkersdorfer B, et al. (2018). Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography. Clin Pharmacol Ther 104:139–47.
   PubMed Web of Science ®Google Scholar
• Bednarczyk D, Boiselle C. (2016). Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. Xenobiotica 46:457–66.
   PubMed Web of Science ®Google Scholar
• Brännström M, Nordell P, Bonn B, et al. (2015). Montelukast disposition: no indication of transporter-mediated uptake in OATP2B1 and OATP1B1 expressing HEK293 cells. Pharmaceutics 7:554–64.
   PubMed Web of Science ®Google Scholar
• Brouwer KL, Keppler D, Hoffmaster KA, et al. (2013). In vitro methods to support transporter evaluation in drug discovery and development. Clin Pharmacol Ther 94:95–112.
   PubMed Web of Science ®Google Scholar
• Chu EJ, Watson CJ. (1947). An experimental study of the cerebral coproporphyrin in rabbits. Proc Soc Exp Biol Med 66:569–70.
   PubMed Web of Science ®Google Scholar
• Chu X, Philip G, Evers R. (2012). Comments on Mougey et al. (2009). Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19: 129-138. Pharmacogenet Genomics 22:319–22.
   PubMed Web of Science ®Google Scholar
• Dawson DA, Wadsworth G, Palmer AM. (2001). A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Res 892:344–50.
   PubMed Web of Science ®Google Scholar
• Eley T, Garimella T, Li W, Bertz RJ. (2015a). Asunaprevir: a review of preclinical and clinical pharmacokinetics and drug–drug interactions. Clin Pharmacokinet 54:1205–22.
   PubMed Web of Science ®Google Scholar
• Eley T, Han YH, Huang SP, et al. (2015b). Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease. Clin Pharmacol Ther 97:159–66.
   PubMed Web of Science ®Google Scholar
• Funai Y, Shirasaka Y, Ishihara M, et al. (2019). Effect of osmolality on the pharmacokinetic interaction between apple juice and atenolol in rats. Drug Metab Dispos 47:386–91.
   PubMed Web of Science ®Google Scholar
• Glaeser H, Bailey DG, Dresser GK, et al. (2007). Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 81:362–70.
   PubMed Web of Science ®Google Scholar
• Karlgren M, Vildhede A, Norinder U, et al. (2012). Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem 55:4740–63.
   PubMed Web of Science ®Google Scholar
• Keiser M, Kaltheuner L, Wildberg C, et al. (2017). The organic anion-transporting peptide 2B1 is localized in the basolateral membrane of the human jejunum and Caco-2 monolayers. J Pharm Sci 106:2657–63.
   PubMed Web of Science ®Google Scholar
• Larson EA, Watson CJ. (1949). Studies of coproporphyrin. II. An investigation of the contribution to the urinary coproporphyrin of hemoglobin and of bacterial metabolism in the intestinal tract. J Clin Invest 28:452–64.
   Web of Science ®Google Scholar
• Lees KR. (1997). Cerestat and other NMDA antagonists in ischemic stroke. Neurology 49:S66–S69.
   PubMed Web of Science ®Google Scholar
• McFeely SJ, Wu L, Ritchie TK, Unadkat J. (2019). Organic anion transporting polypeptide 2B1 - More than a glass-full of drug interactions. Pharmacol Ther 196:204–15.
   PubMed Web of Science ®Google Scholar
• Medwid S, Li MMJ, Knauer MJ, et al. (2019). Fexofenadine and rosuvastatin pharmacokinetics in mice with targeted disruption of organic anion transporting polypeptide 2B1. Drug Metab Dispos 47:832–42.
   PubMed Web of Science ®Google Scholar
• Michel MC, Foster C, Brunner HR, Liu L. (2013). A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev 65:809–48.
   PubMed Web of Science ®Google Scholar
• Mougey EB, Feng H, Castro M, et al. (2009). Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19:129–38.
   PubMed Web of Science ®Google Scholar
• Nozawa T, Imai K, Nezu J, et al. (2004). Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438–45.
   PubMed Web of Science ®Google Scholar
• Prakash A, Spencer CM. (1998). Balsalazide. Drugs 56:83–9.
   PubMed Web of Science ®Google Scholar
• Rebello S, Zhao S, Hariry S, et al. (2012). Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. Eur J Clin Pharmacol 68:697–708.
   PubMed Web of Science ®Google Scholar
• Roberts LM, Black DS, Raman C, et al. (2008). Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155:423–38.
   PubMed Web of Science ®Google Scholar
• Ryde EM, Ahnfelt NO. (1988). The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food. Eur J Clin Pharmacol 34:481–8.
   PubMed Web of Science ®Google Scholar
• Sai Y, Kaneko Y, Ito S, et al. (2006). Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab Dispos 34:1423–31.
   PubMed Web of Science ®Google Scholar
• Shen H, Chen W, Drexler DM, et al. (2017). Comparative evaluation of plasma bile acids, dehydroepiandrosterone sulfate, hexadecanedioate, and tetradecanedioate with coproporphyrins I and III as markers of OATP inhibition in healthy subjects. Drug Metab Dispos 45:908–19.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Fuse K, Okudaira K, et al. (2005). Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans. Drug Metab Dispos 33:1477–81.
   PubMed Web of Science ®Google Scholar
• Shirasaka Y, Mori T, Murata Y, et al. (2014). Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1. Pharm Res 31:2035–43.
   PubMed Web of Science ®Google Scholar
• Tamai I, Nezu J, Uchino H, et al. (2000). Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273:251–60.
   PubMed Web of Science ®Google Scholar
• Tapaninen T, Karonen T, Backman JT, et al. (2013). SLCO2B1 c.935G > A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren. Pharmacogenet Genomics 23:19–24.
   PubMed Web of Science ®Google Scholar
• Unger MS, Mudunuru J, Schwab M, et al. (2020). Clinically relevant OATP2B1 inhibitors in marketed drug space. Mol Pharm 17:488–98.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan S, Camenisch G, Schuetz H, et al. (2008). Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren. J Clin Pharmacol 48:1323–38.
   PubMed Web of Science ®Google Scholar
• Varma MV, Kimoto E, Scialis R, et al. (2017). Transporter-mediated hepatic uptake plays an important role in the pharmacokinetics and drug-drug interactions of montelukast. Clin Pharmacol Ther 101:406–15.
   PubMed Web of Science ®Google Scholar
• Visentin M, Chang MH, Romero MF, et al. (2012). Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1). Mol Pharmacol 81:134–42.
   PubMed Web of Science ®Google Scholar
• Watson CJ, Larson EA. (1947). The urinary coproporphyrins in health and disease. Physiol Rev 27:478–510.
   PubMed Web of Science ®Google Scholar